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Purpose: In-stent restenosis (ISR) is a known complication following carotid artery stenting (CAS). However, ultrasound
criteria determining ISR are not well established. We evaluated alternative ultrasound velocity criteria for >70% ISR in
our institution.
Methods: Clinical records of 256 patients undergoing 282 consecutive CAS procedures over a 42-month period were
reviewed. Follow-up ultrasounds were available for analysis in 237 patients. Selective angiograms and repeat interven-
tions were performed for >70% ISR. Ultrasound criteria including peak systolic velocity (PSV), end diastolic velocity
(EDV), and internal carotid to common carotid artery ratios (ICA/CCA) were examined. The sensitivity, specificity,
positive predictive value (PPV), and negative predictive value (NPV) were calculated for PSV (200, 250, 300, 350, and
400 cm/s), EDV (70, 80, 90, 100 cm/s), and CCA/ICA (3, 3.5, 4, 4.5, 5).
Results: Twenty-two carotid angiograms were performed and 18 lesions had confirmations of >70% ISR in 11 patients
including prior CEA in five patients and neck irradiation in two patients. Receiver operator characteristics (ROC) was
analyzed for PSV, EDV, and CCA/ICA ratio. For 70% or greater angiographic ISR, PSV > 300 cm/s correlated to a 94%
sensitivity, 50% specificity, 90% positive predictive value (PPV), and 67% negative predictive value (NPV); EDV > 90
cm/s correlated to an 89% sensitivity, 100% specificity, 100% PPV, and 67% NPV; and ICA/CCA > 4 had a 94.4%
sensitivity, 75% specificity, 94% PPV, and 75% NPV. A significant color flow disturbance was detected in one patient who
did not meet the aforementioned ultrasound velocity criteria. Further statistical analysis showed that an EDV of 90 cm/s
provided the best discriminant value.
Conclusion: Our study demonstrated that PSV > 300 cm/s, EDV > 90 cm/s, and ICA/CCA > 4 correlated well with
>70% ISR. Although still rudimentary, these velocity criteria combined with color flow patterns can reliably predict
severe ISR in our vascular laboratory. However, due to the relatively infrequent cases of severe ISR following CAS, a
multicentered study is warranted to establish standard post-CAS ultrasound surveillance criteria for severe ISR. ( J Vasc
Surg 2008;47:74-80.)Several large prospective trials have demonstrated that
carotid artery stenting (CAS) is a safe alternative to carotid
endarterectomy (CEA), particularly for high risk-patients
including those with severe cardiopulmonary comorbidi-
ties, recurrent stenosis following endarterectomy, prior
neck irradiation, and inaccessible lesions above the C2
level.1-4 Over the last decade, CAS has become increasingly
adopted in the medical community. As the result, The
Centers for Medicare and Medicaid Services (CMS) has
expanded Medicare coverage for carotid artery stenting in
high-risk patients with 70% symptomatic carotid artery
stenoses. Additionally, high-risk patients who have symp-
tomatic carotid artery stenosis between 50% and 70% and
those who are asymptomatic with an 80% or greater steno-
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Despite the promising results of CAS, questions remain
regarding the long-term durability of this endovascular
treatment modality.5-8 Our study and others has demon-
strated that CAS-related in-stent restenosis (ISR) is not
uncommon, but severe ISR is relatively rare.5-11 Therefore,
it is essential to identify those patients with clinically signif-
icant ISR who warrant further interventions. Current ultra-
sound criteria for classifying the severity of carotid artery
stenosis are deemed unreliable for stented arteries due in
part to the change of arterial wall compliance following
stenting.12-14 Several studies have evaluated ultrasound
criteria for moderate ISR.12,15 Studies on ultrasound crite-
ria for clinically significant high-grade ISR is limited due to
the relatively low incidences of severe ISR following CAS.16
The purpose of this study is to examine our experience of
post-CAS ultrasound surveillance and to evaluate ultra-
sound criteria for clinically significant70% ISR following
CAS.
MATERIAL AND METHODS
Patient selections and stenting procedures. Hos-
pital charts and clinical records were reviewed on all
patients who underwent CAS over a 42-month period
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consecutive CAS procedures were performed on 256 pa-
tients at Baylor College of Medicine-affiliated hospitals,
primarily at Michael E. DeBakey VA Medical Center. Ca-
rotid duplex scans were performed prior to the stenting
procedures, and high-grade carotid stenoses were docu-
mented on all patients. Follow-up ultrasounds were avail-
able for analysis in 237 patients (93%). High-risk patients
with symptomatic carotid stenosis of 70% or greater and
asymptomatic carotid stenoses of 80% or greater were con-
sidered for stenting protocol as described in our previous
studies.9,17 Nonetheless, selected symptomatic patients
with 60% or greater ulcerative lesions were also treated.
Carotid stenting procedures were performed using a
standard protocol. All CAS procedures were performed in
the operating room with the routine use of embolization
protection devices (EPD) including FilterWire system
(Boston Scientific, Natick, Mass), ACCUNET emboliza-
tion protection device (Guidant Co, Santa Clara, Calif),
and Emboshield embolic protection system (Abbott Vas-
cular, Redwood City, Calif). Either an endovascular oper-
ative suite (Siemens, Siemens Medical Systems Inc, Iselin,
NJ) or a mobile fluoroscopic unit (OEC 9800 model, GE
Medical Systems, Salt Lake City, UT) was used for the
procedure. The technical details of CAS has been described
previously.9,17 The stents implanted include Wallstent
(Boston Scientific, Natick, Mass), ACCULINK (Guidant
Co, Santa Clara, Calif), and Xact (Abbott Vascular Devices,
Redwood City, Calif). Post-stenting balloon angioplasty
was performed for over 20% residual stenoses. Completion
angiogram including biplanar carotid and cerebral views
was performed prior to the capture of the EPD to docu-
ment the vascular anatomy and to exclude cerebral throm-
boembolism. The groin puncture site was routinely closed
with a closure device (Perclose or StarClose, Abbott Vas-
cular Devices, Redwood City, Calif).
Ultrasound surveillance. Patients were routinely
kept in the hospital overnight and discharged home the
following day. Follow-up visits with carotid duplex ultra-
sounds were performed at 1, 6, and 12 months following
the interventions and each year thereafter. Patients who
required interventions for clinically significant ISR follow-
ing CAS were evaluated with Duplex ultrasounds at
3-month intervals. Follow-up ultrasounds were available
for analysis in 237 patients. All Duplex ultrasounds were
performed by experienced registered vascular technologists
using Phillips/ATL HDL 5000 SonoCT or Phillips IU 22
ultrasound imaging system (Bothell, Wash) in two vascular
laboratories. Velocities of the common carotid artery
(CCA) were measured proximal to the stent. Velocities of
internal carotid artery (ICA) were measured within the
stent and distal to the stent when feasible. Peak systolic
velocity (PSV) and end diastolic velocity (EDV) of ICA
were obtained at the narrowest portion of ICA within the
stent. The ICA/CCA ratio was calculated based on the
PSV of ICA and CCA. The velocity criteria used to evaluate
carotid artery stenosis in non-stented arteries were modi-
fied from the University of Washington criteria and werevalidated in our laboratories.18 Briefly, peak systolic veloc-
ity (PSV)  125 cm/s, end diastolic velocity (EDV)  140
cm/s, and ICA/CCA  4 correlates to 70% to 79% steno-
sis; and EDV  140 cm/s correlates to 80% stenosis. A
clinically significant stenosis was defined as a luminal reduc-
tion of 70% or higher.
Studies have shown that stented arteries have marked
increased ultrasound velocity.12-14 However, for the pur-
pose of this study, patients with PSV  200 cm/s, EDV 
80 cm/s, or ICA/CCA  3 were identified as potentially
having significant 70% ISR. These preliminary velocity
criteria were chosen to include the patients with potentially
moderate to severe ISR based on our clinical experiences
and were intentionally lower than we anticipated. By doing
so, we increased the sensitivity of ultrasound criteria and,
therefore, achieved an adequate sample size of patients who
underwent angiography. The criteria were also selected to
avoid unnecessary exposure of angiography-related risks for
the majority of the patients. Patients who met any single
criteria were invited for angiographic confirmation. Each
velocity criteria was individually considered and examined
using receiver operator characteristics (ROC) analysis. Ad-
ditionally, luminal reductions on gray-scale images as well
as color flow disturbances were also considered, which are
particularly important for post-stent surveillance.
Angiographic measurement. Patients with poten-
tially 70% ISR as identified on ultrasounds were con-
tacted and subsequently underwent biplanar carotid an-
giography to verify the severity of the stenosis. Typically,
two views of cervical angiography including cross-table
lateral and oblique views were obtained to define the lesion.
Occasionally, an anterior-posterior view was required to
illuminate the lesion. The stenosis was measured geomet-
rically based on the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) criterion using an elec-
tronic caliber and a software package provided by Siemens
Medical Solution. Specifically, the degree of stenosis was
calculated from the ratio of the linear luminal diameter of
the narrowest segment of the stented artery to the diameter
of the internal carotid artery beyond any poststenotic dila-
tation. Carotid angioplasty and possible stenting were sub-
sequently performed following the standard protocol upon
confirmation of the lesions.
Statistical analysis. The ultrasound velocities for
stented arteries with suspected severe ISR were reviewed.
The total number of stented arteries that had both angio-
graphic and sonographic data formed the base of the anal-
ysis. Continuous variables were expressed as mean SEM.
Clinical variables that may be associated with ISR following
CAS were analyzed. Wilcoxon rank sum tests, 2 analyses,
or paired Student t tests were performed where appropri-
ate. ROC curves were used to compare angiographic data
with velocity measurements to determine optimal velocity
criteria for 70% ISR. The sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV),
and accuracy were calculated to determine the optimal
threshold for PSV, EDV, and ICA/CCA ratio in determin-
ing 70% ISR. The test results were considered significant
JOURNAL OF VASCULAR SURGERY
January 200876 Zhou et alat a P value of less than .05. All statistical analyses were
performed using the StatView software program (SAS In-
stitute, Cary, NC).
RESULTS
Clinical outcomes. Two hundred fifty-six patients
successfully underwent 282 consecutive CAS procedures
during the study period. Among them, 117 (46%) patients
were asymptomatic, and 26 patients had bilateral lesions.
Among the 282 successful CAS procedures, the mean
carotid artery stenosis decreased from 85%  12% prior to
the stent placement to a post-stenting mean residual steno-
sis of 10%  5%. Monorail Wallstents (Boston Scientific)
were placed in 224 (79%) carotid arteries. ACCULINK
stents (Guidant) were used in 28 (10%) procedures and
Xact stents (Abbott Vascular) in 30 (11%) procedures. The
mean in-hospital length of stay was 1.7  1.4 days. The
overall 30-day stroke and death rate was 2.5% (n  7).
There are no significant differences in perioperative mortal-
ity and morbidities among three stent systems.
Follow-up ultrasound evaluation. In addition to
four perioperative deaths, 15 patients were lost to follow-
up. A total of 237 patients were available for ultrasound
evaluation during a mean follow-up of 32 months (range, 6
months to 48 months). These patients underwent ultra-
sound surveillance at 1 month, 6 months, 1 year, and yearly
thereafter. Patients with increased flow velocities or sus-
pected ISR were evaluated at 3-month intervals. During
the follow-up period, 34 patients died of various causes that
were unrelated to the procedures. A total of 22 carotid
angiograms were performed on patients with suspected
severe ISR based on ultrasound velocity criteria (Table I).
Eighteen angiograms (7.6%) confirmed 70% ISR on
11 patients including prior CEA in five patients, neck
irradiation in two, and neck dissection in one. Three pa-
tients presented with recurrent ISR. Among them, one
patient had multiple bilateral recurrences (patient 2, Table
I) that required repetitive interventions on six different
occasions. Clinical characteristics of these patients are listed
in Table II. Among the significant ISR, four lesions were
symptomatic (22.2%) including two lesions that caused
strokes, one associated with transient ischemic attack, and
one that led to amaurosis fugax. Specificity, sensitivity,
PPV, and NPV of various ultrasound measurements were
analyzed including multiple potential thresholds for PSV,
EDV, and ICA/CCA ratio. The results are shown in Table
III. Data derived from the ROC curves were used to
calculate the parameters of accuracy for PSV (Fig 1, a),
EDV (Fig 1, b), and ICA/CCA ratio (Fig 1, c) through a
wide range of values to determine the optimal threshold for
70% ISR. A larger area under the ROC curve measures
improved discrimination. Based on these criteria, the area
under the curve (area  SE) and significance (P) were
calculated for various ultrasound velocity values. Our anal-
ysis showed that EDV provided the best discriminative
power (Fig 2). Further analyses showed ICA PSV of 293
cm/s on ROC curve corresponded to a 94.4% sensitivity
and 50% specificity. We decided PSV of 300 cm/s as thecutoff point, which yielded 89.5% PPV, 66.7%NPV, and an
overall accuracy of 86.4%. Additionally, EDV of 89.5 cm/s
corresponded to an 89% sensitivity and 100% specificity on
Table I. Ultrasound evaluations and angiographic results















1 1 320 116 5.2 Yes
2 2 482 199 5.7 Yes
3 414 188 3.9 Yes
4 434 212 5.1 Yes
5 601 306 28.6 Yes
6 355 162 4.0 Yes
7 377 96 5.2 Yes
3 8 322 90 14.0 Yes
9 431 104 9.0 Yes
4 10 422 90 7.3 Yes
5 11 266 75 5.9 Yes
6 12 509 173 8.1 Yes
13 488 175 8.4 Yes
7 14 475 170 5.1 Yes
8 15 420 90 5.7 Yes
9 16 420 89 5.6 Yes
10 17 581 159 9.8 Yes
11 18 360 114 5.4 Yes
12 19 387 63 1.3 No
13 20 350 88 6.3 No
14 21 232 76 3.0 No
15 22 247 67 3.5 No
ICA, Internal carotid artery; PSV, peak systolic velocity; EDV, end diastolic
velocity; ICA/CCA ratio, internal carotid artery to common carotid artery
peak systolic velocity ratio.
Table II. Clinical characteristics of patients with
angiographic evident ISR (70%)
Number, %
Total number of patients 11
Total number of carotid artery with 70% ISR 18
Male gender 10 (90.9%)
Age (y) 77 (55-87)
Severe ISR carotid lesions (total n  18)
Asymptomatic 14 (77.8%)
Stroke 2 (11.1%)
Transient ischemic attack 1 (5.6%)
Amaurosis fugax 1 (5.6%)
Patient comorbidities (total n  11)
Coronary artery disease 7 (63.4%)
Congestive heart failure 3 (27.3%)
Hypertension 10 (90.9%)
Diabetes 5 (45.5%)
Chronic obstructive pulmonary disease 4 (36.4%)
Renal insufficiency (creatinine 1.5 mg/dl) 1 (9.1%)
Anatomical limitations (total n  11)
History of neck radiation 2 (18.2%)
Post-CEA restenosis 5 (45.4%)
s/p radical neck dissection 1 (9.1%)
High-carotid bifurcation 1 (9.1%)
ISR, In-stent restenosis; CEA, carotid endarterectomy.ROC curve analysis. We chose EDV of 90 cm/s as a cutoff
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overall accuracy of 90.9%. Furthermore, various thresholds
of ICA/CCA ratios were also examined and revealed an
ICA/CCA of 3.95 correlated to a 94.4% sensitivity, 75.0%
specificity. A cutoff point of 4.0 yielded 94.4% PPV, 75.0%
NPV, and an overall accuracy of 90.9%. Several combina-
tions of PSV, EDV, and ICA/CCA ratio were also evalu-
ated. However, combinations of various ultrasound veloc-
ity criteria did not improve the accuracy of predicting
70% ISR.
Management for significant ISR. All patients under-
went endovascular interventions, and the average time in-
terval of reintervention from the initial CAS procedure was
11 months (range, 1 month to 24 months). Technical
successes as defined by the resolution of the stenosis after
treatment were achieved in all patients. The mean carotid
artery stenosis decreased from 88% to 16% after reinterven-
tion. No procedural-related complications were noted fol-
lowing ISR intervention. All patients received baseline ul-
trasound evaluations at 1 month following the procedure.
Significant velocity decreases in ultrasound parameters
were observed including a PSV decrease by 55.2% (P  .03)
and EDV by 67.9% (P  .02). However, a decrease in
ICA/CCA ratio did not reach statistical significance (P 
.17) (Table IV). During a median follow-up period of 18
months following ISR intervention, three patients devel-
oped recurrent stenoses including one patient with multi-
ple recurrences. Additional interventions using a cutting
balloon angioplasty were successfully performed and one
patient required an additional stent placement.
DISCUSSION
We, along with several other investigators, have dem-
Table III. Parameters of ICA PSV, EDV, and












400 67 100 100 40 73
350 83 50 88 40 77
300 94 50 90 67 86
250 100 50 90 100 91
200 100 0 82 82
ICA EDV (cm/s)
100 67 100 100 40 73
90 89 100 100 67 91
80 94 75 94 75 91
70 100 50 90 100 91
ICA/CCA ratio
5 89 75 94 60 86
4.5 89 75 94 60 86
4 94 75 94 75 91
3.5 100 50 90 100 91
3 100 25 86 100 91
ICA, Internal carotid artery; PSV, peak systolic velocity; EDV, end diastolic
velocity; ICA/CCA ratio, internal carotid artery to common carotid artery
peak systolic velocity ratio; PPV, positive predictive value; NPV, negative
predictive value.onstrated that moderate ISR following carotid stenting isnot uncommon and post-procedural follow-ups are essen-
tial in identifying those patients with hemodynamically
significant ISR that require interventions.8-10,16 The du-
plex ultrasound, a sensitive and widely available image
modality, is an ideal screening tool for de novo stenosis of
carotid artery and post-CEA restenosis. However, carotid
ultrasound is deemed unreliable for post-stent surveillance
in early studies largely due to lack of well-established ultra-
sound criteria and falsely elevated velocities associated with
increased stiffness of the stented ICA. Although several
recent studies have reported ultrasound criteria for mild
and moderate ISR, studies investigating severe ISR are
limited due in part to the low incidences of severe ISR and
relatively short follow-up in most centers.8,16,19 In this
study, we identified a relatively larger number of signif-
icant ISR (70%) that required interventions in our
high-volume center and performed systemic analyses to
categorize the optimal threshold for ultrasound criteria.
Several studies have shown that ISR is a well-
documented late complication following carotid artery
stenting.5,7,11 Our experience of carotid stenting echoes
their observation. In our study, the majority (71%) of
significant ISR were identified during the 6-month or
12-month ultrasound follow-up. The average time interval
of reintervention for significant ISR from the initial CAS
procedure in our series was 11 months ranging from 1
month to 24 months. We have also observed decreased
ultrasound velocities over time in selected patients who
presented with moderately elevated velocity during the
initial follow-up ultrasound. However, we were not able to
identify factors predictive of ultrasound progression or
regression. Particularly, one patient presented with multi-
ple bilateral severe ISR that required interventions. His
bilateral ISR occurred consecutively, thus, the ultrasound
velocity of the suspected side was not affected by the
contralateral side as the contralateral side had relatively
normal velocity. We, therefore, decided not necessary to
exclude this patient from our study. Ultimately, the
progress of the ultrasound velocity on this patient had
reduced 36 months following the initial stenting proce-
dure. The incidence of hemodynamically significant ISR in
our study is 7.6% over a 32-month follow-up period, which
remained consistent with other clinical series. However,
two patients refused diagnostic angiogram or any further
intervention despite significantly elevated ultrasound veloc-
ities. Among whom, one patient had an isolated increase in
ICA PSV 18 months following cutting balloon angioplasty
for severe ISR. We, therefore, estimate that the true inci-
dence of ISR may be slighter higher. Although we did not
find difference in ISR rates, perioperative mortality or mor-
bidities among different carotid stents used, the small co-
hort of patients who received ACCULINK or Xact stents
precluded us from draw a valid conclusion.
Several investigators have attempted to establish ultra-
sound criteria for ISR following CAS. Lal and associates
compared post-carotid stenting ultrasound velocities with
angiographically measured residual in-stent stenosis follow-
ing CAS and proposed a new criteria of PSV  150 cm/s
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sound criteria for severe ISR were, however, not examined
in their study. Stanziale and colleagues retrospectively re-
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detected by carotid duplex using cut-off values of 170 cm/s
PSV, 120 cm/s EDV, and 50% increase over immediate
postoperative values. Like others, we have previously exam-
ined moderate ISR (60%).9 However, a moderate ISR
typically does not warrant urgent treatment. In this study,
we examined follow-up ultrasound evaluations of 237 pa-
tients to determine clinically significant ISR that require
prompt intervention. Although the consensus is still lacking
on treatment threshold for ISR, it is generally accepted that
70% ISR is considered significant and should be intervened.
We, therefore, determined to evaluate ultrasound velocity
criteria correlating to 70% ISR. In addition, diameter re-
duction on gray-scale and significant color flow disturbance
were also considered. Although we did not analyze the
progress of ultrasound velocity following CAS procedures,
we have observed reduction of velocities over time in
selected patients as mentioned previously. We, therefore,
postulate that the initial ultrasound does not predict the
risk of ISR and serial follow-up ultrasound evaluations are
necessary to detect significant ISR.
Unlike other studies, our analysis showed that ultra-
sound velocity criteria for greater than 70% ISR is surpris-
ingly similar to the criteria for non-stented arteries in our
vascular laboratory in spite of much higher observed values
of PSV, EDV, and ICA/CCA ratios in the arteries with
severe ISR. This observation likely reflects the operator and
laboratory-dependent nature of ultrasound measurement.
To determine the optimal value, ROC curves were analyzed
for PSV, EDV, and ICA/CCA. Our ROC analysis showed
no optimal value for ISR, and that EDV greater than 90
cm/s or ICA/CCA greater than 4.0 corresponded to the
most accurate ultrasound velocity profiles. Although PSV
of 300 cm/s is less sensitive than PSV of 250 cm/s, the
small but definitive risks of carotid angiograms prompted
us to choose PVS of 300 cm/s as the threshold for signifi-
cant ISR. Our chosen criteria, particularly PSV, may sacri-
fice sensitivity in change for specificity. Additionally, statis-
tical selection bias can not be excluded as we only included
those patients with elevated velocities and high likelihoods
for significant ISR. Despite our effort of intentionally low-
ering velocity criteria for selective angiogram, the total
patient cohort for ROC analysis was relatively small due to
low incidence of severe ISR. In order to minimize the
Fig 2. The area under the ROC curve (area  SE) and signifi-
cance (P) were calculated for various ultrasound velocity values
including PSV, EDV, and ICA/CCA ratio. Our analysis showed
that EDV provided the best discriminative power.statistical bias, we will need to subject an additional numberof patients to invasive angiograms and contrast exposure.
We believe that it is unnecessary to expose patients to these
potential risks. Moreover, we analyzed the ultrasound ve-
locity of the patients who did not meet velocity criteria for
carotid angiograms, and compared the ultrasound veloci-
ties of the patients who underwent carotid angiograms with
those who did not receive angiograms. Using a student t
test analysis with unequal variances, we demonstrated that
the velocities of these two groups hadminimal overlap (P
.05). The significantly different distribution patterns of the
two groups further confirmed that the number of patients
with significant ISR but did not receive carotid angiogram
was extremely small. Therefore, we advocate utilizing the
aforementioned velocity thresholds along with color flow
disturbance and gray-scale imaging to detect significant
ISR. Nonetheless, other noninvasive diagnostic modalities,
such as computed tomography (CT) angiogram and mag-
netic resonance imaging (MR) angiogram, perhaps should
be utilized to validate ultrasound velocity criteria in future
studies.
In addition to identifying severe ISR using ultrasound
velocity criteria, our study also showed significant changes
in velocity parameters following a successful intervention
for ISR, particularly PSV and EDV. ICA/CCA ratio did
not reach statistical significant despite marked decrease in
value. Although we did not find a correlation between the
postintervention velocity and the likelihood of recurrent
ISR (P  .05), we demonstrated that postintervention
ultrasound velocities can be used to indicate success of
interventions and as a baseline for long-term follow-up
after CAS procedures.
Admittedly, there are certain limitations to our study.
Although it is the largest series of significant ISR following
CAS to date, our series only comprised of 18 carotid
arteries with 70% ISR during a mean follow-up of 32-
months. This relatively limited patient cohort is largely due
to a low incidence of severe ISR following CAS and inade-
quate detection criteria to identify the patients for repeat
carotid angiogram. The ultrasound evaluations of carotid
stents were retrospectively reviewed, and only patients with
markedly increased ultrasound velocities underwent angio-
graphic confirmation. We, therefore, may have underesti-
mated a small number of stented arteries with false negative
ultrasound values. However, the incidence of presumed
false negative studies is extremely low, and we did not
believe that it is justified to perform angiograms on a wide
sample of our patient population as mentioned previously.
It is also important to recognize that our velocity criteria is
established in our own laboratory where all duplex ultra-
sounds were performed by experienced registered vascular
technologists using Phillips/ATL HDL 5000 SonoCT or
Phillips IU 22 ultrasound imaging system. We did not
compare our results with other laboratories or other scan-
ner models. Therefore, it is crucial for individual vascular
laboratory to validate its own duplex criteria to establish
reliable ultrasound criteria for clinically significant ISR.
In conclusion, our study demonstrated that PSV 300
cm/s, EDV 90 cm/s, and ICA/CCA 4 correlated well
veloc
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combined with color flow pattern and gray-scale image can
reliably predict severe ISR. Our study also demonstrated
that postintervention ultrasound criteria were useful in
confirming the success of the procedures and can be used as
a baseline for long-term follow-up after carotid artery stent-
ing. The proposed velocity thresholds in this study form the
basis for additional multicentered prospective validation
studies to further establish standard post-CAS ultrasound
surveillance criteria. Moreover, each vascular laboratory
may need to establish local ultrasound criteria for detecting
significant ISR.
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